Anti-S1 MERS-COV IgY Specific Antibodies Decreases Lung Inflammation and Viral Antigen Positive Cells in the Human Transgenic Mouse Model

The Middle East respiratory syndrome coronavirus (MERS-CoV) was identified in 2012 and causes severe and often fatal acute respiratory illness in humans. No approved prophylactic and therapeutic interventions are currently available. In this study, we have developed egg yolk antibodies (immunoglobul...

Descripción completa

Detalles Bibliográficos
Autores principales: Abbas, Aymn T., El-Kafrawy, Sherif A., Sohrab, Sayed Sartaj, Tabll, Ashraf A., Hassan, Ahmed M., Iwata-Yoshikawa, Naoko, Nagata, Noriyo, Azhar, Esam I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712919/
https://www.ncbi.nlm.nih.gov/pubmed/33139631
http://dx.doi.org/10.3390/vaccines8040634

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712919/
https://www.ncbi.nlm.nih.gov/pubmed/33139631
http://dx.doi.org/10.3390/vaccines8040634

Ejemplares similares